Refine by
Transfer Patient Articles & Analysis
31 news found
Portsmouth, N.H. – IV dislodgement is a near-daily problem for clinicians and their patients, according to a recent focus group of vascular access experts. The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in ...
QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a medical technology company committed to making kidney care more accessible with its SC+ haemodialysis system, has released a new report that suggests people with kidney failure who wish to do home dialysis face unequal access across the UK. The Bridging the Gap report finds that failure to offer such treatment ...
Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area. Until now, patients needing routine or ...
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview ...
Mobile robots helps staff to optimize disinfection The Blue Ocean Robotics range of mobile robots helps staff to optimize disinfection, telepresence and the safe transfer and rehabilitation of patients. The company has a wide base of customers, including commercial cleaning company ISS, hospitals, schools, airports, hotel chains, production companies and ...
Experience our innovative virtual reality (VR) therapy system CUREO live at the MEDICA, November 15-18, 2021. We will be at the NRW booth in hall 3, booth number C80. We will also give presentations and talk about the advantages that come with virtual reality-based therapy Come by and check out live demonstrations of our smart therapy system that supports cognitive and sensorimotor ...
The portfolio of robots includes the brands UVD Robots; GoBe Robots - a telepresence robot for reducing travel time, costs and CO2 emissions; and PTR Robots - a safe patient transfer and rehabilitation robot for improving the health of caregivers and patients. ...
User Involvement during Usability Testing of the PTR Robot - a Medical Robotic Device for Patient Transfer and Rehabilitation Fernanda Nunes will present a poster that is part of a broader investigation conducted by the User Experience team from Blue Ocean Robotics. ...
The robot will on a daily basis assist the staff with safe patient transfers. Using the PTR Robot will support the caregivers in improving the working environment and make it safer to work with patient transfers. ...
“With EU funds, the European Commission is buying 200 disinfection robots, which will be delivered to hospitals across Europe to help disinfect patient rooms. We do all we can to support hospitals and patients in these difficult times. ...
The portfolio of robots includes the brands UVD Robots - a robot that provide efficient and automated disinfection solutions for hospitals and life science customers and have been clinically tested and verified; GoBe Robots - a telepresence robot for reducing travel time, costs and CO2 emissions; and PTR Robots - a safe patient transfer and rehabilitation robot ...
NEW YORK, Feb. 25, 2021 /PRNewswire/ -- miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced today that its Chairman & CEO, Sam Salman, will be virtually presenting at the 12th Annual Prostate Cancer Awareness Day at the Massachusetts State House ...
CoapTech, a leading medical device start-up pioneering the world’s first and only ultrasound-based feeding tube placement system, announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement. CoapTech Inc ...
ByCoapTech
Synaptive Medical, a leader in robotic surgical and imaging technologies, announced today the company has established a partnership with O-Two Medical Technologies, Inc., a world leader in controlled ventilation, for the production of O-Two’s e700 portable transport ventilator for patients impacted worldwide by COVID-19. As part of the agreement, Synaptive will leverage its expertise in ...
You wish the best for your patients, and following surgery or treatment, it is imperative to understand how their bodies are reacting. Obviously this concerns following up at intervals. However, patients are often under the impression that following up is unnecessary and expensive if they feel fine. The cardiac monitor experts at Medicomp take a look at the realities of patient follow-ups. ...
The symposium will feature recent clinical experience and case studies from several leading U.S. structural heart centers, highlighting the safety and efficacy of the Tempo Lead, its use in TAVR procedures, its positive impact on facilitating post-TAVR patient ambulation outside of the ICU and CCU, and its role in reducing length of stay. ...
RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended Limb Tourniquets. The TX series joins the XSTAT® injectable hemostatic on the TCCC list of recommended hemorrhage control devices for casualty care. Andrew Barofsky, President and CEO of RevMedx, ...
ByRevMedx
In addition, the Tempo Lead allows patients to ambulate sooner after procedures such as TAVR and TMVR, accelerating recovery times, and enabling patient transfer directly to a step-down or telemetry unit instead of an ICU or CCU. ...
Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, announced today that it has entered into a strategic collaboration to work with Actelion Pharmaceuticals Ltd, a Janssen pharmaceutical company of Johnson & Johnson. The collaboration will bring the global resources and know-how of the largest and most respected healthcare ...
In addition, the Tempo Lead allows patients to ambulate sooner after procedures such as TAVR and TMVR, accelerating recovery times, and enabling patient transfer directly to a step-down or telemetry unit instead of an ICU or CCU. ...